Abiopharma

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001918704-26-018397 <b>Size:</b> 758 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001214659-26-007907 <b>Size:</b> 901 KB

New Form 424B5 - Jefferies Financial Group Inc. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001140361-26-026871 <b>Size:</b> 473 KB

(70% Positive) PALVELLA THERAPEUTICS, INC. (PVLA) Announces New Board Appointment

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0000950103-26-009752 <b>Size:</b> 219 KB

📋 Thomas E. Hogan (Director and Officer) plans to sell 283K shares of Cellebrite DI Ltd. (at $14.18 each, total $4.0M) Filed: Jun 30, 2026 | ID: 046137

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001918704-26-018396 <b>Size:</b> 791 KB

New Form 424B5 - Jefferies Financial Group Inc. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001140361-26-026868 <b>Size:</b> 769 KB

New Form 424B5 - Jefferies Financial Group Inc. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001140361-26-026869 <b>Size:</b> 624 KB

Asset Acquisitions and Disposals: Completion of Proposed Disposal of An Office Unit at 20 Cecil Street, #06-02 PLUS, Singapore 049705